UnitedHealth Group stock holds near recent support with RSI approaching oversold levels: weekly analysis

Traders Union
All News
Stocks
Unitedhealth slips 1.15% this week

Highlights

Shares of UnitedHealth Group fell 1.15% over the past 7 days to $397.45, trading below both the 20-day and 50-day averages.
Short-term momentum is turning negative with multiple indicators in or near oversold territory and bearish signals prevailing.
Immediate support stands at $391.59 and resistance at $407.32, with a projected range of $370.01 to $404.48 next week and a 67% probability of a decrease.

Dividend hike and Medicare exits steer sentiment as legal scrutiny lingers

The board of UNH authorized a quarterly cash dividend of $2.32 per share to be paid on September 22, 2026, according to an announcement on the company's site and as reported by AOL and Yahoo Finance. UNH also detailed exits from certain Medicare Advantage plans that will impact over 600,000 members and lead to an anticipated enrollment decline of around 1.1 million by year-end 2026, along with a new target for Medicare margins above 3%. Second-quarter results beat analyst expectations, with adjusted EPS at $6.38 and updated full-year guidance, while management cited improved margins from cost discipline and business mix, and ongoing regulatory scrutiny continues to pose legal and governance risks, as noted by Claims Journal, Benzinga, and ad-hoc-news.de.

Oscillator-based downside pressure intensifies as support endures this week

On the daily chart, the setup reflects an emerging move lower that is not yet confirmed, with volatility at 4.02%. The RSI is at 38.37 and approaching oversold territory, while the CCI and Stochastic RSI both sit in oversold zones, highlighting growing downside pressure. The MACD remains firmly in sell mode, reinforcing the negative short-term tone. Immediate support is marked at $391.59, with resistance at $407.32 and the Ichimoku Kijun at $426.61 acting as a higher resistance level.

Bearish bias and downside risk remain in focus for the coming week

Next week, the expected range stands at $370.01 to $404.48, with a 33% probability of an increase and 67% probability of a decrease. The base case calls for trading between the support at $391.59 and the resistance at $407.32 as bearish momentum develops. A sustained move above $407.32 would turn attention to higher resistance levels, while a break below $391.59 would open the door to further downside toward the $370.01 mark.

Jainam Mehta, market strategist, sees UnitedHealth’s slide this week as a continuation of bearish momentum, with price action now straining key supports near $391.59. He notes that technical signals remain negative, though macro-related regulatory risks and the impact of planned Medicare exits add to market caution. Next week, he expects trading to remain range-bound unless a significant break occurs above resistance or below support. "With sentiment turning negative but the setup nearing oversold, I’m watching for a decisive move outside the $391.59–$407.32 band before considering any tactical shift."

Earlier, analysts noted that UnitedHealth Group was experiencing building downside momentum, with technical signals pointing to unresolved direction as the stock entered oversold territory. The current outlook reinforces these downside risks, as increased bearish pressure and recent developments in Medicare Advantage operations leave support at $391.59 as a critical level to watch for further market direction.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.